Discover the New Formulation Rybelsus Tablets

September 16, 2025 (Current Version)
September 16, 2025
September 16, 2025
Introduction
Launched UK-wide in September 2025, the new Rybelsus® (semaglutide) tablets are smaller and use lower dose strengths while delivering similar treatment effects.
See How NowPatient Helps with All Your Health and Medication Needs
Take one tablet daily on an empty stomach after approximately 8 hours fasting, with ≤120 ml water, and wait ≥30 minutes before food, drink, or other oral medications. Always follow your prescriber’s advice.
Key takeaways
- Smaller tablets & reduced dose numbers (1.5/4/9 mg replace 3/7/14 mg) for similar effects.
- How you take it hasn’t changed: on empty stomach, with small amount of water.
- Side-effect profile and expected outcomes remain consistent.
- UK safety: report issues via the MHRA Yellow Card and contact Novo Nordisk support.
- US safety: report issues via the MedWatch
Table of contents
- Why the new Rybelsus formulation?
- What’s changed
- What’s stayed the same
- How to take Rybelsus (step-by-step)
- Quick tips
- Reporting side effects (UK)
- FAQs
- Final thoughts
Why the New Rybelsus Formulation? A Smarter Way to Manage Your Blood Sugar
The new Rybelsus tablets are engineered for better absorption, so you can achieve similar treatment effects with smaller doses and tinier tablets, making day-to-day diabetes management simpler.
For UK adults already prescribed Rybelsus, this educational guide complements (not replaces) your package leaflet and clinician’s advice.
What’s Changed in Your New Rybelsus Tablets?
- Reduced doses with the same expected effects
- Smaller tablets for easier swallowing
- Slimmer packaging for convenience
Dose equivalence at a glance:
Previous Rybelsus Tablets | New Rybelsus Tablets |
---|---|
3 mg | 1.5 mg |
7 mg | 4 mg |
14 mg | 9 mg |
Remember, your clinician or pharmacist will guide any transition.
What Has Stayed the Same? No Surprises in Your Routine
- Treatment effects: Expect comparable blood sugar control (weight changes may occur, speak with your clinician).
- How you take it: Instructions are unchanged.
- Possible side effects: Similar profile; monitor as before.
How to Take Your New Rybelsus Tablets: Step-by-Step Guide
- Time it right: Take on an empty stomach after ~8 hours fasting (mornings work well).
- Swallow whole: Use no more than 120 ml (about half a glass) of water. Don’t split, crush, or chew.
- Wait it out: ≥30 minutes before eating, drinking anything else, or taking other oral medicines.
Missed a dose? Skip it and take the usual dose the next day. Don’t double.
Took too much? Contact your doctor straight away (you may feel nauseous).
Don’t stop suddenly without medical advice, blood sugar may rise.
Quick Tips for Treatment Success with Rybelsus
- One tablet per day only.
- Keep tablets in original packaging to protect from light and moisture.
- Set a consistent morning routine (alarm, water glass ready).
- If you take other morning medications, ask your pharmacist about timing’s for your dose.
Reporting Side Effects: Stay Safe with Rybelsus
- Speak to your doctor, pharmacist, or nurse promptly.
- Report directly via the MHRA Yellow Card Scheme (website or the “MHRA Yellow Card” app in Google Play/Apple App Store).
- You can also contact Novo Nordisk Customer Care Centre: 0800 023 2573 (calls may be recorded for training).
Frequently Asked Questions
What changed with the new tablets?
Smaller tablets, lower numerical dose strengths (1.5/4/9 mg), and smaller packaging, with similar treatment effects.
Do I need to relearn how to take Rybelsus?
No. The administration stays the same: empty stomach → ≤120 ml water → wait ≥30 minutes.
What if I miss a dose?
Skip it and take your usual dose the next day. Don’t take an extra tablet.
Can I stop if I feel fine?
Don’t stop without medical advice. Blood sugar levels can rise after stopping.
Storage tips?
Keep tablets in their original packaging until use to protect from light and moisture.
Final Thoughts: Embrace the New Rybelsus for Easier Diabetes Management
The 2025 Rybelsus update focuses on smarter, simpler treatment with smaller doses and tablets, same expected effects. For personalised guidance, speak with your healthcare professional and read your package leaflet.
Prepared: September 2025. For UK adults already prescribed Rybelsus. Educational use only; not medical advice. Rybelsus® is a registered trademark of Novo Nordisk A/S.
Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Related Articles
Can I Trust NowPatient
Certified to International Healthcare, Medical Device and Data Security Standards
Medicines Experts
Meet Our Medical Team
We are a broad skilled and passionate group of clinicians with experience of operating in health systems in the United Kingdom & United States. Providing excellent care and advice is at the heart of everything we do. You can read more about our medical team by visiting the medical team page or learn more about how we curate content by visiting our editorial process
WHY WE BUILT NOWPATIENT
We Are Committed to Helping Everyone, Everywhere Live Healthier Lives
The NowPatient virtual care platform provides you with access to trusted health information, affordable treatments, management of chronic health conditions and continuous monitoring for health risks. NowPatient can be accessed by downloading the App or using your web browser.
Download our app today

Your Questions Answered
For Your Peace of Mind, We Can Answer Your Questions Quickly
What does NowPatient do?
NowPatient is a digital health-technology platform functioning as both an online pharmacy and telehealth service. Packaged as a Class I software medical device, it’s accessible via web browser or mobile app (iOS and Android), and offers users worldwide on-demand access to virtual consultations, prescription services, and AI-powered health tools.
What It Does
-
- NHS Online Pharmacy: Order NHS-approved prescriptions (UK)
- Drug Savings: Access major US drug-savings programs (coupons, savings cards, manufacturer assistance, Canadian drug savings).
- Virtual Consultations: Get treated for a wide range of medical conditions by expert clinicians using a secure telehealth link.
- Medication Management: Set up refill & dose reminders, view private treatment plans, and track chronic conditions like diabetes or hypertension.
- Health-Monitoring Tools: Use AI-driven assessments for genetic risk tests, home test kits and blood-pressure monitoring.
- Wellness Insights: Access real-time pollen counts, air-quality data, BMI and type 2 diabetes risk scores, plus comprehensive health-condition information.
Get started today and benefit from Medication Reminders, Get Treated Privately, NHS Online Pharmacy, GP Appointment Booking, Rx Savings Card, Drug Coupons, US Drug Savings Programs, Health Conditions Information, Genetic Testing, Home Test Kits, BMI Risks, Type 2 Diabetes Risks, Pollen Meter, Air Quality Monitor, and lots more!
Our service is operated by experienced medical professionals in the United States and the United Kingdom.
Where is NowPatient located?
NowPatient has offices in the United Kingdom and United States.
In the UK, we are located at:
NowPatient
28 Chipstead Valley Road
Coulsdon
Surrey
CR52RA
In the US, we are located at:
NowPatient
8911 North Capital of Texas Highway
Suite 4200 #1263
78759
Austin, TX
How can I contact NowPatient?
To contact NowPatient, please use the contact form available on the Contact Us page.
Alternatively, if you need to speak to us, you can reach us on the following numbers:
UK telephone number – 020 388 51 500
US telephone number – 1-866-967-1977
Who owns NowPatient?
NowPatient is owned and operated by Infohealth Ltd, a licensed online pharmacy with services spanning the UK, US and Rest of the World. Infohealth Ltd is registered in England and Wales under company number 04004930 and our registered office is at Lynwood House, 373 – 375 Station Road, Harrow, England, HA1 2AW.
Our website is www.nowpatient.com. Our App is called “NowPatient” and can be downloaded from the App Store (for Apple devices) or Google Play (for Android devices).
Can you tell me more about your NHS online pharmacy?
NowPatient’s Pharmaceutical services in the UK are provided by Infohealth Limited trading as ‘Infohealth Pharmacy’.
Our dispensing pharmacy is regulated and authorized for internet sales by the General Pharmaceutical Council (GPhC), registration number 1036487. You can view our license credentials on the General Pharmaceutical Council website. Our superintendent pharmacist who is responsible for the safe and effective oversight of medicines supplies is Mr Amish Patel (Registration Number 2042705).
Medicines are not ordinary items of commerce. All medicines or healthcare product sales are made under the supervision of a registered pharmacist who is licensed by the GPhC. At all times, we endeavour to provide a professional and transparent service whose primary goal is to ensure that the best interests of the patient are served.
How do I make a complaint?
From time to time, we accept that our service levels may not be up to your expectations. NowPatient welcomes concerns, compliments and complaints as valuable feedback that will help us learn from your experiences and make improvements. Feedback can be provided via our clear and transparent Complaints Procedures.
Can you tell me more about NowPatient’s prescribing services for treatments offered?
Our prescribing services are regulated by the General Pharmaceutical Council (GPhC). We provide the following regulated activity:
• treatment of disease, disorder, or injury
• transport services, triage, and medical advice are provided remotely
• caring for adults over 65 years old
• caring for adults under 65 years old
NowPatient prescribing services are run by Infohealth Limited. The Clinical Safety Officer and nominated individual is Mr Navin Khosla. Dr Ihtesham Sabri is the Medical Director for NowPatient and is responsible for NowPatient’s prescribing formulary and treatment guidelines, which are used by clinicians for safe and effective prescribing.
Can you tell me more about NowPatient’s US services?
Our head of US services is Dr. Jamie Winn.
You can lower the cost of your prescription medications using our various savings programs which include drug coupons, savings card and manufacturer-sponsored patient assistance programs.
What are the steps to booking a live video consultation?
Follow the steps below to book a consultation:
If I place an order, how do I check out?
Follow the steps below to checkout:
Is NowPatient legit and can I trust information from NowPatient?
Yes. NowPatient provides trustworthy and accessible clinical, health education and prescription services. We are also trusted by the NHS to deliver clinical and NHS repeat prescription dispensing across the whole of England. In the United States, we work with over 65,000 pharmacies to deliver considerable costs savings for our users.
NowPatient is operated by experienced licensed medical professionals in the United Kingdom and United States. Our Medical Team can be found here.
Our service is trusted by thousands of patients worldwide. You can read their reviews on our Trustpilot:
Does NowPatient have insurance in place for the services it provides?
Yes. NowPatient is fully insured to provide pharmacy & prescribing services. Insurance not only provides peace of mind but also provides an effective safety net for both you and our clinicians.
Why is it important to choose an online pharmacy and telehealth service that is insured?
Insurance is more than just a financial safeguard, it is a signal of legitimacy and accountability.
We insure our services, so that it:
- Shows you that we are compliant with all laws and industry standards in the markets that we operate.
- Shows you that we are committed to standards of professionalism.
- Reinforces your confidence that you are dealing with a reputable provider.
Who insures your services and which services are insured?
We are insured by the National Pharmacy Association in the UK.
The scope of the services covered include:
- dispensing of prescriptions
- telehealth prescribing services.
In addition, all of the clinicians that operate on our platform have their personal indemnity insurance & scope of clinical practice validated and checked before they are able to provide services.
What are NowPatient’s opening hours?
Our office hours are:
UK – Monday-Friday 9am-6pm GMT
US – Monday-Friday 8am-5pm EST
Please note that we are closed at weekends.
In the event of a medical life-threatening emergency please call:
UK – 999
US – 911
In the event of a medical emergency which is not life-threatening please call:
UK – 111